The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study.

MLA

Kraaijenhof, Jordan M., et al. “The Role of Systemic Inflammation in Remnant Cholesterol Associated Cardiovascular Risk: Insights from the EPIC-Norfolk Study.” European Journal of Preventive Cardiology, Feb. 2025. EBSCOhost, https://doi.org/10.1093/eurjpc/zwaf037.

APA

Kraaijenhof, J. M., Kerkvliet, M. J., Nurmohamed, N. S., Grefhorst, A., Kroon, J., Wareham, N. J., Hovingh, G. K., Stroes, E. S. G., Boekholdt, S. M., & Reeskamp, L. F. (2025). The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwaf037

Chicago

Kraaijenhof, Jordan M, Marije J Kerkvliet, Nick S Nurmohamed, Aldo Grefhorst, Jeffrey Kroon, Nicholas J Wareham, G Kees Hovingh, Erik S G Stroes, S Matthijs Boekholdt, and Laurens F Reeskamp. 2025. “The Role of Systemic Inflammation in Remnant Cholesterol Associated Cardiovascular Risk: Insights from the EPIC-Norfolk Study.” European Journal of Preventive Cardiology, February. doi:10.1093/eurjpc/zwaf037.